Document Detail


Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening.
MedLine Citation:
PMID:  22150506     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background:  Gestational diabetes mellitus is a potentially serious condition that affects many pregnancies and its prevalence is increasing. Evidence suggests early detection and treatment improves outcomes, but this is hampered by continued disagreement and inconsistency regarding many aspects of its diagnosis. Methods:  The Vitamin D and Lifestyle Intervention for Gestational Diabetes Mellitus Prevention (DALI) research programme aims to promote pan-European standards in the detection and diagnosis of gestational diabetes and to develop effective preventive interventions. To provide an overview of the context within which the programme will be conducted and its findings interpreted, systematic searching and narrative synthesis have been used to identify and review the best available European evidence relating to the prevalence of gestational diabetes, current screening practices and barriers to screening. Results:  Prevalence is most often reported as 2-6% of pregnancies. Prevalence may be lower towards the Northern Atlantic seaboard of Europe and higher in the Southern Mediterranean seaboard. Screening practice and policy is inconsistent across Europe, hampered by lack of consensus on testing methods, diagnostic glycaemic thresholds and the value of routine screening. Poor clinician awareness of gestational diabetes, its diagnosis and local clinical guidelines further undermine detection of gestational diabetes. Conclusions:  Europe-wide agreement on screening approaches and diagnostic standards for gestational diabetes could lead to better detection and treatment, improved outcomes for women and children and a strengthened evidence base. There is an urgent need for well-designed research that can inform decisions on best practice in gestational diabetes mellitus screening and diagnosis. © 2011 The Authors. Diabetic Medicine© 2011 Diabetes UK.
Authors:
B S Buckley; J Harreiter; P Damm; R Corcoy; A Chico; D Simmons; A Vellinga; F Dunne;
Related Documents :
19268536 - Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 a...
20632216 - Glycolaldehyde induces oxidative stress in the heart: a clue to diabetic cardiomyopathy?
17182776 - Previous experience with behavioral control over stress blocks the behavioral and dorsa...
20156986 - The role of mitochondria in the pathogenesis of type 2 diabetes.
8339856 - Metformin effects on peripheral sensitivity to insulin in non diabetic obese subjects.
15625086 - Glut4 expression and subcellular localization in the intrauterine growth-restricted adu...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-12
Journal Detail:
Title:  Diabetic medicine : a journal of the British Diabetic Association     Volume:  -     ISSN:  1464-5491     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8500858     Medline TA:  Diabet Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.
Affiliation:
School of Medicine, National University of Ireland, Galway, Ireland Department of Medicine, Medizinische Universität Wien, Austria University Hospital of Copenhagen - Rigshospitalet, Denmark Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona, Spain Institute of Metabolic Science, Addenbrookes Hospital, Cambridge, UK Department of General Practice, National University of Ireland, Galway, Ireland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Caudal Mediastinal Paraesophageal Abscesses in 7 Dogs.
Next Document:  Modelling the concentration-time relationship in milk from cattle administered an intramammary drug.